Bovine Colostrum Supplementation in Athletes
Effect of Bovine Colostrum Supplementation on Neutrophil Function in Recreational Athletes
1 other identifier
interventional
32
1 country
1
Brief Summary
32 recreational athletes who will attend to the Grand Marathon in the nort west of Mexico, event that will be held on December 2, 2018 or 21k Trail to be held in April 2019 will be invited to the study. Participants will be informed about the study procedures through a consent informed. Participants will be randomly divided into two groups, 16 in the intervention group and 16 in the comparison group. The participants will be recreational athletes between 18 and 60 years old. They must have athletic experience of at least 3 years. The participants considered will be those who perform vigorous physical activity per week according to the criteria of the short version IPAQ instrument. Smoking subjects with food intolerances and allergies, cardiovascular history will be excluded. Patients who have had a respiratory infection symptom in the last two weeks will not be able to participate in the study. Participants who are consuming some type of food supplement will be excluded. Two 18 ml of blood samples will be taken from the vein of the forearm by venipuncture of each participant, using K2EDTA tubes after and before supplementation period. Blood samples were taken before a corporal, aerobic and nutritional evaluations. CB supplementation will begin 4 weeks prior to competition events. One group will consume 20 g of bovine colostrum daily in solution with water. The second group will consume a placebo product with a nutritional composition similar to the group with the treatment of bovine colostrum. Both groups should take the supplement before breakfast with empty stomach.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 10, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 13, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
April 5, 2019
CompletedFirst Submitted
Initial submission to the registry
October 16, 2023
CompletedFirst Posted
Study publicly available on registry
November 9, 2023
CompletedNovember 9, 2023
November 1, 2023
1 month
October 16, 2023
November 3, 2023
Conditions
Outcome Measures
Primary Outcomes (8)
Neutrophil phagocytic capacity
Percentage of phagocytic neutrophils
Before and after 4 weeks of supplementation
Monocytes phagocytic capacity
Percentage of phagocytic monocytes
Before and after 4 weeks of supplementation
neutrophils producing reactive oxygen species
percentage of positive cells to fluorescence intensity by flow cytometry
before and after 4 weeks of supplementation
neutrophils reactive oxygen species production intensity
Mean intensity fluorescent by cells measured by flow cytometry
Before and after 4 weeks of supplementation
Monocytes producing reactive oxygen species
percentage of positive cells to fluorescence intensity by flow cytometry
before and after 4 weeks of supplementation
Monocytes reactive oxygen species production intensity
Mean intensity fluorescent by cells measured by flow cytometry
Before and after 4 weeks of supplementation
VO2Max
Indicates participants aerobic condition (ml/kg/min)
Before and after 4 weeks of supplementation
Days presenting upper respiratory tract symptoms
Total of days that participants refers any kind of upper respiratory symptoms
During supplementation 4 weeks of supplementation
Secondary Outcomes (6)
Weight
before and after 4 weeks of supplementation
Height
before and after 4 weeks of supplementation
Body fat
before and after 4 weeks of supplementation
Fat free mass
before and after 4 weeks of supplementation
Energy consumption
before, after 2 and 4 weeks of supplementation
- +1 more secondary outcomes
Study Arms (2)
Colostrum bovine
EXPERIMENTALSubjets taking a colostrum supplement
Placebo
PLACEBO COMPARATORSubjets taking a commercial dairy product
Interventions
Colostrum bovine supplements, 25 kcal per portion, containing 0.25 g fats, 2.0 g CHO and 3 g protein. Lactose reduced.
Dairy comercial product. 25 kcal per portion, 1.3 g fats, 1.95 CHO and 1.3 protein. Lactose based.
Eligibility Criteria
You may qualify if:
- at least 3 years of training experience
- training for a half marathon competition
- No smokers
- Taking any kind of food supplements
- No alimentary allergies
You may not qualify if:
- Injuries
- not follow experimental indications
- cardiovascular disease
- treatment intolerances
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centro de Investigación en Alimentación y Desarrollo
Hermosillo, Sonora, 83304, Mexico
Related Publications (18)
Hackney AC, Koltun KJ. The immune system and overtraining in athletes: clinical implications. Acta Clin Croat. 2012 Dec;51(4):633-41.
PMID: 23540172BACKGROUNDLi TL, Gleeson M. The effect of single and repeated bouts of prolonged cycling on leukocyte redistribution, neutrophil degranulation, IL-6, and plasma stress hormone responses. Int J Sport Nutr Exerc Metab. 2004 Oct;14(5):501-16. doi: 10.1123/ijsnem.14.5.501.
PMID: 15673097BACKGROUNDPeake J, Suzuki K. Neutrophil activation, antioxidant supplements and exercise-induced oxidative stress. Exerc Immunol Rev. 2004;10:129-41.
PMID: 15633591BACKGROUNDTritto ACC, Amano MT, De Cillo ME, Oliveira VA, Mendes SH, Yoshioka C, Roschel H, Camara NOS, Gualano B, Artioli GG. Effect of rapid weight loss and glutamine supplementation on immunosuppression of combat athletes: a double-blind, placebo-controlled study. J Exerc Rehabil. 2018 Feb 26;14(1):83-92. doi: 10.12965/jer.1835154.577. eCollection 2018 Feb.
PMID: 29511657BACKGROUNDBermon S, Castell LM, Calder PC, Bishop NC, Blomstrand E, Mooren FC, Kruger K, Kavazis AN, Quindry JC, Senchina DS, Nieman DC, Gleeson M, Pyne DB, Kitic CM, Close GL, Larson-Meyer DE, Marcos A, Meydani SN, Wu D, Walsh NP, Nagatomi R. Consensus Statement Immunonutrition and Exercise. Exerc Immunol Rev. 2017;23:8-50.
PMID: 28224969BACKGROUNDJones AW, Thatcher R, March DS, Davison G. Influence of 4 weeks of bovine colostrum supplementation on neutrophil and mucosal immune responses to prolonged cycling. Scand J Med Sci Sports. 2015 Dec;25(6):788-96. doi: 10.1111/sms.12433. Epub 2015 Feb 28.
PMID: 25727914BACKGROUNDShing CM, Peake J, Suzuki K, Okutsu M, Pereira R, Stevenson L, Jenkins DG, Coombes JS. Effects of bovine colostrum supplementation on immune variables in highly trained cyclists. J Appl Physiol (1985). 2007 Mar;102(3):1113-22. doi: 10.1152/japplphysiol.00553.2006. Epub 2006 Nov 9.
PMID: 17095643BACKGROUNDRathe M, Muller K, Sangild PT, Husby S. Clinical applications of bovine colostrum therapy: a systematic review. Nutr Rev. 2014 Apr;72(4):237-54. doi: 10.1111/nure.12089. Epub 2014 Feb 26.
PMID: 24571383BACKGROUNDCrooks CV, Wall CR, Cross ML, Rutherfurd-Markwick KJ. The effect of bovine colostrum supplementation on salivary IgA in distance runners. Int J Sport Nutr Exerc Metab. 2006 Feb;16(1):47-64. doi: 10.1123/ijsnem.16.1.47.
PMID: 16676703BACKGROUNDSoligard T, Steffen K, Palmer D, Alonso JM, Bahr R, Lopes AD, Dvorak J, Grant ME, Meeuwisse W, Mountjoy M, Pena Costa LO, Salmina N, Budgett R, Engebretsen L. Sports injury and illness incidence in the Rio de Janeiro 2016 Olympic Summer Games: A prospective study of 11274 athletes from 207 countries. Br J Sports Med. 2017 Sep;51(17):1265-1271. doi: 10.1136/bjsports-2017-097956. Epub 2017 Jul 29.
PMID: 28756389RESULTPalmer-Green D, Elliott N. Sports injury and illness epidemiology: Great Britain Olympic Team (TeamGB) surveillance during the Sochi 2014 Winter Olympic Games. Br J Sports Med. 2015 Jan;49(1):25-9. doi: 10.1136/bjsports-2014-094206. Epub 2014 Nov 25.
PMID: 25425714RESULTMcCarthy DA, Macdonald I, Grant M, Marbut M, Watling M, Nicholson S, Deeks JJ, Wade AJ, Perry JD. Studies on the immediate and delayed leucocytosis elicited by brief (30-min) strenuous exercise. Eur J Appl Physiol Occup Physiol. 1992;64(6):513-7. doi: 10.1007/BF00843760.
PMID: 1618188RESULTDavison G, Diment BC. Bovine colostrum supplementation attenuates the decrease of salivary lysozyme and enhances the recovery of neutrophil function after prolonged exercise. Br J Nutr. 2010 May;103(10):1425-32. doi: 10.1017/S0007114509993503. Epub 2009 Dec 24.
PMID: 20030905RESULTPyne DB, Baker MS, Fricker PA, McDonald WA, Telford RD, Weidemann MJ. Effects of an intensive 12-wk training program by elite swimmers on neutrophil oxidative activity. Med Sci Sports Exerc. 1995 Apr;27(4):536-42.
PMID: 7791584RESULTRobson PJ, Blannin AK, Walsh NP, Castell LM, Gleeson M. Effects of exercise intensity, duration and recovery on in vitro neutrophil function in male athletes. Int J Sports Med. 1999 Feb;20(2):128-35. doi: 10.1055/s-2007-971106.
PMID: 10190775RESULTSantos VC, Levada-Pires AC, Alves SR, Pithon-Curi TC, Curi R, Cury-Boaventura MF. Changes in lymphocyte and neutrophil function induced by a marathon race. Cell Biochem Funct. 2013 Apr;31(3):237-43. doi: 10.1002/cbf.2877. Epub 2012 Sep 13.
PMID: 22972482RESULTBrinkworth GD, Buckley JD. Concentrated bovine colostrum protein supplementation reduces the incidence of self-reported symptoms of upper respiratory tract infection in adult males. Eur J Nutr. 2003 Aug;42(4):228-32. doi: 10.1007/s00394-003-0410-x.
PMID: 12923655RESULTCrooks C, Cross ML, Wall C, Ali A. Effect of bovine colostrum supplementation on respiratory tract mucosal defenses in swimmers. Int J Sport Nutr Exerc Metab. 2010 Jun;20(3):224-35. doi: 10.1123/ijsnem.20.3.224.
PMID: 20601740RESULT
MeSH Terms
Interventions
Study Officials
- PRINCIPAL INVESTIGATOR
Jesús Hernández, PhD
Centro de Investigación en Alimentación y Desarrollo A.C.
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 16, 2023
First Posted
November 9, 2023
Study Start
October 10, 2018
Primary Completion
November 13, 2018
Study Completion
April 5, 2019
Last Updated
November 9, 2023
Record last verified: 2023-11